Iatrogenic Cardiovascular Complications : Part III. Interventional Procedures
1999; Wiley; Volume: 12; Issue: 5 Linguagem: Inglês
10.1111/j.1540-8183.1999.tb00262.x
ISSN1540-8183
AutoresRajiv Maraj, Pairoj Rerkpattanapipat, Nattawut Wongpraparut, Moises Fraifeld, Gary S. Ledley, Larry E. Jacobs, Shahriar Yazdanfar, Morris N. Kotler,
Tópico(s)Cardiac, Anesthesia and Surgical Outcomes
ResumoJournal of Interventional CardiologyVolume 12, Issue 5 p. 371-388 Free to Read Iatrogenic Cardiovascular Complications: Part III. Interventional Procedures RAJIV MARAJ M.D., RAJIV MARAJ M.D. Division of Cardiology, Albert Einstein Medical Cenier, Philadelphia, PennsylvaniaSearch for more papers by this authorPAIROJ RERKPATTANAPIPAT M.D., PAIROJ RERKPATTANAPIPAT M.D. Division of Cardiology, Albert Einstein Medical Cenier, Philadelphia, PennsylvaniaSearch for more papers by this authorNATTAWUT WONGPRAPARUT M.D., NATTAWUT WONGPRAPARUT M.D. Division of Cardiology, Albert Einstein Medical Cenier, Philadelphia, PennsylvaniaSearch for more papers by this authorMOISES FRAIFELD M.D., MOISES FRAIFELD M.D. Division of Cardiology, Albert Einstein Medical Cenier, Philadelphia, PennsylvaniaSearch for more papers by this authorGARY S. LEDLEY M.D., GARY S. LEDLEY M.D. Division of Cardiology, Albert Einstein Medical Cenier, Philadelphia, PennsylvaniaSearch for more papers by this authorLARRY E. JACOBS M.D., LARRY E. JACOBS M.D. Division of Cardiology, Albert Einstein Medical Cenier, Philadelphia, PennsylvaniaSearch for more papers by this authorSHAHRIAR YAZDANFAR M.D., SHAHRIAR YAZDANFAR M.D. Division of Cardiology, Albert Einstein Medical Cenier, Philadelphia, PennsylvaniaSearch for more papers by this authorMORRIS N. KOTLER M.D., Corresponding Author MORRIS N. KOTLER M.D. Division of Cardiology, Albert Einstein Medical Cenier, Philadelphia, PennsylvaniaAddress for reprints: Morris N. Kotler, M.D., Albert Einstein Medical Center, 363 Klein Professional Building, 5401 Old York Road, Philadelphia, PA 19141. Fax: (215) 455–1933.Search for more papers by this author RAJIV MARAJ M.D., RAJIV MARAJ M.D. Division of Cardiology, Albert Einstein Medical Cenier, Philadelphia, PennsylvaniaSearch for more papers by this authorPAIROJ RERKPATTANAPIPAT M.D., PAIROJ RERKPATTANAPIPAT M.D. Division of Cardiology, Albert Einstein Medical Cenier, Philadelphia, PennsylvaniaSearch for more papers by this authorNATTAWUT WONGPRAPARUT M.D., NATTAWUT WONGPRAPARUT M.D. Division of Cardiology, Albert Einstein Medical Cenier, Philadelphia, PennsylvaniaSearch for more papers by this authorMOISES FRAIFELD M.D., MOISES FRAIFELD M.D. Division of Cardiology, Albert Einstein Medical Cenier, Philadelphia, PennsylvaniaSearch for more papers by this authorGARY S. LEDLEY M.D., GARY S. LEDLEY M.D. Division of Cardiology, Albert Einstein Medical Cenier, Philadelphia, PennsylvaniaSearch for more papers by this authorLARRY E. JACOBS M.D., LARRY E. JACOBS M.D. Division of Cardiology, Albert Einstein Medical Cenier, Philadelphia, PennsylvaniaSearch for more papers by this authorSHAHRIAR YAZDANFAR M.D., SHAHRIAR YAZDANFAR M.D. Division of Cardiology, Albert Einstein Medical Cenier, Philadelphia, PennsylvaniaSearch for more papers by this authorMORRIS N. KOTLER M.D., Corresponding Author MORRIS N. KOTLER M.D. Division of Cardiology, Albert Einstein Medical Cenier, Philadelphia, PennsylvaniaAddress for reprints: Morris N. Kotler, M.D., Albert Einstein Medical Center, 363 Klein Professional Building, 5401 Old York Road, Philadelphia, PA 19141. Fax: (215) 455–1933.Search for more papers by this author First published: 08 June 2007 https://doi.org/10.1111/j.1540-8183.1999.tb00262.x Supported in part by Women's League for Medical Research, Albert Einstein Medical Center. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 151 Lincoff AM, Popma JJ, Ellis SG, et al. Abrupt vessel closure complicating coronary angioplasty: Clinical, angiographic and therapeutic profile. J Am Coll Cardiol 1992; 19: 926–935. 152 Detre KM, Holmes DR Jr, Holubkov R, et al. Incidence and consequences of periprocedural occlusion. The 1985–1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation 1990; 82: 739–750. 153 Holmes DR Jr., Simpson JB, Berdan LG, et al. Abrupt closure: The CAVEAT I experience. J Am Coll Cardiol 1995; 26: 1494–1500. 154 Lincoff AM, Topol EJ. Interventional catheterization techniques. In: DS Baim, W Grossman, eds. Cardiac Catheterization, Angiography, and Intervention. Baltimore : Williams and Wilkins, 1995, pp. 1366–1389. 155 Carrozza JP, Baim DS. Complications of directional coronary atherectomy: Incidence, causes, and management. Am J Cardiol 1993; 72: 47E–54E. 156 Cohen BM, Weber VJ, Reisman M, et al. Coronary perforation complicating rotational ablation: The U.S. Multicenter Experience. Cathet Cardiovasc Diagn 1996; 3: 55–59. 157 Abbo KM, Dooris M, Glazier S, et al. Features and outcome of no-reflow after percutaneous coronary intervention. Am J Cardiol 1995; 75: 778–782. 158 Piana RN, Paik GY, Moscussi M, et al. Incidence and treatment of no-reflow after percutaneous coronary intervention. Circulation 1994; 89: 2514–2518. 159 Safian RD, Niazi KA, Strzelecki M, et al. Detailed angiographic analysis of high-speed mechanical rotational atherectomy in human coronary arteries. Circulation 1993; 88: 961–968. 160 Bertrand ME, Lablanche JM, Leroy F, et al. Percutaneous transluminal coronary rotary ablation with rotahlator (European experience). Am J Cardiol 1992; 69: 470–474. 161 Meier B, Gruentzig AR, King III SB. Risk of side branch occlusion during coronary angioplasty. Am J Cardiol 1984; 53: 10–14. 162 Baim DS. Coronary angioplasty. In: DS Baim, W Grossman, eds. Cardiac Catheterization, Angiography, and Intervention. Baltimore : Williams and Wilkins, 1995, pp. 552–554. 163 Oesterle SN, McAuley BJ, Buchbinder M, et al. Angioplasty at coronary bifurcations: Single-guide, two-wire technique. Cathet Cardiovasc Diagn 1986; 12: 57–63. 164 Kimmel SE, Berlin JA, Laskey WK. The relationship between coronary angioplasty procedure volume and major complications. JAMA 1006;274: 1137–1142. 165 Preliminary tabulations from the angioplasty volume. Bethesda (MD): ACC National Database Library, December 1, 1994. 166 Holmes DR Jr, Holubkov R, Vlietstra RE, et al. Comparison of complications during percutaneous transluminal coronary atherectomy from 1977 to 1981 and from 1985 to 1986: The National Lung and Blood Institute Percutaneous Transluminal Coronary Artery Registry. J Am Coll Cardiol 1988; 12: 1149–1155. 167 Bittl JA. Advances in coronary angioplasty. N Engl J Med 1996; 335: 1290–1302. 168 The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 1996; 335: 217–225. 169 King, III SB, Yeh W, Holubkov R, et al. Balloon angioplasty versus new device intervention: Clinical outcomes. A comparison of the NHLBIPTCA and NACI Registries. J Am Coll Cardiol 1998; 31: 558–566. 170 King SB 3rd, Lembo NJ, Weinraub WS, et al. A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST). N Engl J Med 1994; 331: 1044–1050. 171 Landzherg BR, Frishman WH, Lerrick K. Pathophysiology and pharmalogical approaches for prevention of coronary artery restenosis following coronary artery balloon angioplasty and related procedures. Prog Cardiovasc Dis 1997; 39: 361–398. 172 Hirshfeld JW, Ellis SG, Faxon DP, et al. Recommendations for the assessment and maintenance of proficiency in coronary interventional procedures. Statement of the American College of Cardiology. J Am Call Cardiol 1998; 31: 722–743. 173 Waksman R, Ghazzal ZMB, Baim DS, et al. Myocardial infarction as a complication of new interventional devices. Am J Cardiol 1996; 78: 751–756. 174 Simpfendorfer C, Belardi J, Bellamy G, et al. Frequency, management and follow-up of patients with acute coronary occlusions after percutaneous transluminal coronary angioplasty. Am J Cardiol 1987; 59: 267–269. 175 Meyerovitz MF, Friedman PL, Ganz P, et al. Acute occlusion developing during or immediately after percutaneous transluminal coronary angioplasty: Non-surgical treatment. Radiology 1988; 169: 491–494. 176 Burkhard-Meier C, Von Arnim TH, Stablein A, et al. Major complications of PTCA: Analysis of 500 patients(abstract). Eur Heart J 1988; 9(Suppl. 1): 218. 177 Sinclair IN, McCabe CH, Sipperly ME, et al. Predictors, therapeutic options and long-term outcome of abrupt reclosure. Am J Cardiol 1988; 61: 61G–66G. 178 Gabliani G, Deligonul U, Kern MJ, et al. Acute coronary occlusion occurring after successful percutaneous transluminal coronary angioplasty: Temporal relationship to discontinuation of anticoagulation. Am Heart J 1988; 116: 696–700. 179 Gaul G, Hollman J, Simpfendorfer C, et al. Acute occlusion in multiple lesion coronary angioplasty: Frequency and management. J Am Coll Cardiol 1989; 13: 283–288. 180 The EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 1997; 336: 1689–1696. 181 Ellis SG, Roubin GS, King III SB, et al. Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty. Circulation 1988; 77: 372–379. 182 Ellis SG, Roubin GS, King III SB, et al. In-hospital cardiac mortality after acute closure after coronary angioplasty: Analysis of risk factors from 8207 procedures. J Am Coll Cardiol 1988; 11: 211–216. 183 Sharma SK, Israel DH, Kamean JL, et al. Clinical, angiographic, and procedural determinants of major and minor coronary dissection during angioplasty. Am Heart J 1993; 126: 39–47. 184 Bell MR, Reeder GS, Garratt KN, et al. Predictors of major ischemic complications after coronary dissection following angioplasty. Am J Cardiol 1993; 71: 1402–1407. 185 Kuntz RE, Piana R, Pomerantz RM, et al. Changing incidence and management of abrupt closure following coronary intervention in the new device era. Cathet Cardiovasc Diagn 1992; 27: 183–190. 186 Maiello L, Colombo A, Gianrossi R, et al. Coronary stenting for treatment of acute or threatened closure following dissection after coronary balloon angioplasty. Am Heart J 1993; 125: 1570–1575. 187 Holmes DR Jr., Simpson JB, Berdan LG, et al. Abrupt Closure: The CAVEAT I Experience. J Am Coll Cardiol 1995; 26: 1494–1500. 188 George BS, Voorhees III WD, Roubin GS, et al. Multicenter investigation of coronary stenting to treat acute or threatened closure after percutaneous transluminal coronary angioplasty: Clinical and angiographic outcomes. J Am Coll Cardiol 1993; 22: 135–43. 189 Antoniucci D, Santoro GM, Bolognese L, et al. Bailout Palmaz-Schatz coronary stenting in 39 patients with occlusive dissection complicating conventional angioplasty. Cathet Cardiovasc Diagn 1995; 35: 204–209. 190 Altmann DB, Racz M, Battleman DS, et al. Reduction in angioplasty complications after the introduction of coronary stents: Results from a consecutive series of 2242 patients. Am Heart J 1996; 132: 503–507. 191 Holmes DR Jr., Gersh BJ, Bailey KR, et al. Emergency “rescue” percutaneous transluminal coronary angioplasty after failed thrombolysis with streptokinase. Early and late results. Circulation 1990; 81(Suppl. IV): IV–51–IV–56. 192 Koren G, Weiss AT, Hasin Y, et al. Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase. N Engl J Med 1985; 313: 1384–1389. 193 Mathey DG, Sheehan FH, Schofer J, et al. Time from onset of symptoms to thrombolytic therapy: A major determinant of myocardial salvage in patients with acute transmural infarction. J Am Coll Cardiol 1985; 6: 518–525. 194 White HD, Norris RM, Brown MA, et al. Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction. N Engl J Med 1987; 317: 850–855. 195 Sheehan FH, Braunwald E, Canner P, et al. The effect of intravenous thrombolytic therapy on left ventricular function: A report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) Trial. Circulation 1987; 75: 817–829. 196 Ellis SG, Van De Werf F, Ribeiro Da Silva ER, et al. Present status of rescue coronary angioplasty: Current polarization of opinion and randomized trials. J Am Coll Cardiol 1992; 19: 681–686. 197 Ellis SG, Ribeiro Da Silva ER, Heyndrickx GR, et al., For the RESCUE Investigators. Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction. Circulation 1994; 90: 2280–2284. 198 Baim DS, Diver DJ, Knatterud GL, and The TIMI II-A Investigators. PTCA “salvage” for thrombolytic failures-implications from TIMI II-A(abstract). Circulation 1988;(Suppl. II): II–112. 199 Fung AY, Lai P, Toplo EJ, et al. Value of percutaneous transluminal coronary angioplasty after unsuccessful intravenous streptokinase therapy in acute myocardial infarction. Am J Cardiol 1986; 58: 686–691. 200 The TIMI Research Group. Immediate versus delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction. JAMA 1988; 260: 2849–2858. 201 Holmes DR Jr, Gersh BJ, Bailey KR, et al. Emergency “rescue” percutaneous transluminal coronary angioplasty after failed thrombolysis with streptokinase. Early and late results. Circulation 1990; 81(Suppl. IV): IV–51–IV–56. 202 McKendall GR, Foman S, Sopko G, et al, and The Thrombolysis in Myocardial Infarction Investigators. Value of rescue percutaneous transluminal coronary angioplasty following unsuccessful thrombolytic therapy in patients with acute myocardial infarction. Am J Cardiol 1995; 76: 1108–1111. 203 Gibson CM, Cannon CP, Greene RM, et al. for the TIMI 4 Study Group. Rescue angioplasty in the Thrombolysis in Myocardial Infarction (TIMI) 4 trial. Am J Cardiol 1997: 80: 21–26. 204 Califf RM, Abdelmeguid AE, Kuntz RE, et al. Myonecrosis after revascularization procedures. J Am Coll Cardiol 1998; 31: 241–251. 205 Abdelmeguid AE, Whitlow PL, Sapp SK, et al. Long-term outcome of transient, uncomplicated in-laboratory coronary artery closure. Circulation 1995, 91: 2733–2741. 206 Harrington RA, Lincoff AM, Califf RM, et al. Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: Insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT). J Am Coll Cardiol 1995; 25: 1693–1699. 207 Abdelmeguid AE, Topol EJ, Whitlow PL, et al. Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. Circulation 1996; 94: 1528–1536. 208 Elliott JM, Berdan LG, Holmes DR, et al. One year follow-up in the Coronary Angioplasty versus Excisional Atherectomy Trial (CAVEAT I). Circulation 1995; 91: 2158–2166. 209 Kong TQJ, Davidson CJ, Meyers SN, et al. Prognostic implication of creatine kinase elevation following elective coronary interventions. JAMA 1997; 277: 461–466. 210 Topol EJ, Ferguson JJ, Weisman HF, et al. Long-term protection from myocardial ischemic events in a randomized trial of brief integrin B3 blockade with percutaneous coronary intervention. JAMA 1997; 278: 479–484. 211 Baim DS, Kent KM, King III SB, et al. Evaluating new devices. Acute (In-hospital) results from the new approaches to coronary intervention registry. Circulation 1994; 89: 471–481. 212 Safian RD, Baim DS, Kuntz RE. Coronary atherectomy. In: DS Baim, W Grossman, eds. Cardiac Catheterization, Angiography, and Intervention. Baltimore : Williams and Wilkins, 1995, pp. 581–616. 213 Popma JJ, Topol EJ, Hinohara T, et al. Abrupt vessel closure after directional coronary atherectomy. J Am Coll Cardiol 1992; 19: 1372–1379. 214 Rowe MH, Hinohara T, White NW, et al. Comparison of dissection rates and results following directional coronary atherectomy and coronary angioplasty. Am J Cardiol 1990; 66: 49–53. 215 Fishman RF, Kuntz RE, Carrozza JP, et al. Long term results of directional coronary atherectomy: predictors of restenosis. J Am Coll Cardiol 1992; 20: 1101–1110. 216 Ajluni SC, Glazier S, Blankenship L, et al. Perforations after percutaneous coronary interventions. Clinical, angiographic and therapeutic observations. Cathet Cardiovasc Diagn 1994; 32: 206–212. 217 Pomerantz RM, Kuntz RE, Carrozza JP, et al. Acute and long-term outcome of narrowed saphenous vein grafts treated by endoluminal stenting and directional atherectomy. Am J cardiol 1992; 70: 161–167. 218 Warth DC, Leon MB, O'Neill W, et al. Rotational atherectomy multicenter registry: Acute results, complications and 6-month angiographic follow-up in 709 patients. J Am Coll Cardiol 1994; 24: 641–648. 219 Reisman M, Harms V, Whitlow P, et al. Comparison of early and recent results with rotational atherectomy. J Am Coll Cardiol 1997; 29: 353–357. 220 Dietz U, Erbel R, Rupprecht H-J, et al. High frequency rotational ablation: An alternative in treating coronary artery stenoses and occlusions. Br Heart J 1993: 70: 327–336. 221 Ellis SG, Popma JJ, Buchbinder M, et al. Relation of clinical presentation, stenosis morphology, and operator technique to the procedural results of rotational atherectomy and rotational atherectomy-facilitated angioplasty. Circulation 1994; 89: 882–892. 222 Teirstein PS, Warth DC, Haq N, et al. High speed rotational coronary atherectomy for patients with diffuse coronary artery disease. J Am Coll Cardiol 1991; 18: 1694–1701. 223 Misumi K, Matthews RV, Guo-Wen Sun, et al. Reduced distal embolization with transluminal extraction atherectomy compared to balloon angioplasty for saphenous vein graft disease. Cathet Cardiovasc Diagn 1996; 39: 246–251. 224 Twidale N, Barth III CW, Kipperman RM, et al. Acute results and long-term outcome of transluminal extraction catheter atherectomy for saphenous vein graft stenoses. Cathet Cardiovasc Diagn 1994; 3l: 187–191. 225 Safian RD, Grines CL, May MA, et al. Clinical and angiographic results of transluminal extraction coronary atherectomy in saphenous vein bypass grafts. Circulation 1994; 89: 302–312. 226 Popma JJ, Leon, MB Mintz, et al. Results of coronary angioplasty using the transluminal extraction catheter. Am J Cardiol 1992; 70: 1526–1532. 227 Transluminal extraction catheter for the treatment of diseased saphenous vein grafts: A multicenter experience. Cathet Cardiovasc Diagn 1995; 34: 112–120. 228 Safian RD, May MA, Lichtenberg A, et al. Detailed clinical and angiographic analysis of transluminal extraction coronary atherectomy for complex lesions in native coronary arteries. J Am Coll Cardiol 1995; 25: 848–854. 229 Litvack F, Eigler N, Margolis J, et al. Percutaneous excimer laser coronary angioplasty: Results in the first consecutive 3000 patients. J Am Coll Cardiol 1994; 23: 323–329. 230 Ghazzal ZMB, Heran JA, Litvack F, et al. Morphological predictors of acute complications after percutaneous excimer laser coronary angioplasty. Results of a comprehensive angiographic analysis: Importance of the eccentricity index. Circulation 1992; 86: 820–827. 231 Bittl JA, Sanborn TA. Excimer-laser-facilitated coronary angioplasty. Relative risk analysis of acute and follow-up results in 200 patients. Circulation 1992; 86: 71–80. 232 Eigler NL, Weinstock B, Douglas JS Jr, et al. Excimer laser coronary angioplasty of aorto-ostial stenoses. Results of the excimer laser coronary angioplasty (ELCA) registry in the first 200 patients. Circulation 1993; 88(Part 1): 2049–2057. 233 Bittl JA, Sanborn TA, Tcheng JE, et al. Clinical success, complications and restenosis rates with excimer laser coronary angioplasty. Am J Cardiol 1992; 70: 1533–1539. 234 Sanborn TA, Bittl JA, Hershman RA, et al. Percutaneous coronary excimer laser-assisted angioplasty: Initial multicenter experience in 141 patients. J Am Coll Cardiol 1991; 17: 169B–173B. 235 Holmes DR Jr, Reeder GS, Ghazzal ZMB, et al. Coronary perforation after excimer laser coronary angioplasty: The excimer laser coronary angioplasty registry experience. J Am Coll Cardiol 1994; 23: 330–335. 236 Bittl JA, Ryan TJ Jr, Keaney JF Jr, et al. Coronary artery perforation during excimer laser coronary angioplasty. J Am Coll Cardiol 1993; 21: 1158–1165. 237 Holmes DR Jr, Forrester JS, Litvack F, et al. Chronic total obstruction and short-term outcome: The excimer laser coronary angioplasty registry experience. Mayo Clin Proc 1993; 68: 5–10. 238 Bittl JA, Sanborn TA, Yardley DE, et al. Predictors of outcome of percutaneous excimer laser coronary angioplasty of saphenous vein bypass graft lesions. Am J Cardiol 1994; 74: 144–148. 239 Deckelbaum LI, Natarajan MK, Bittl JA, et al. for the Percutaneous Excimer Laser Coronary Angioplasty (PELCA) Investigators. Effect of intracoronary saline infusion on dissection during excimer laser coronary angioplasty: A randomized trial. J Am Coll Cardiol 1995; 26: 1264–1269. 240 Carrozza, JP Jr, Kuntz RE, Levine MJ, et al. Angiographic and clinical outcome of intracoronary stenting: Immediate and long-term results from a large single-center experience. J Am Coll Cardiol 1992; 20: 328–337. 241 Eeckhout E, Goy Jean-Jacques, Vogt P, et al. Complications and follow-up after intracoronary stenting: Critical analysis of a 6-year single-center experience. Am Heart J 1994; 127: 262–272. 242 Baim DS, Kent KM, King III SB, et al. for the NACI investigators. Evaluating new devices. Acute (in-hospital) results from the new approaches to coronary intervention registry. Circulation 1994; 89: 471–481. 243 Laham RJ, Ho KKL, Baim DS, et al. Multivessel Palmaz-Schatz stenting: Early results and one-year outcome. J Am Coll Cardiol 1997; 30: 180–185. 244 Savage MP, Douglas JS Jr, Fischman DL, et al. for the Saphenous Vein De Novo Trial Investigators. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. N Engl J Med 1997; 337: 740–747. 245 Hong MK, Popma JJ, Baim DS, et al. Frequency and predictors of major in-hospital ischemic complications after planned and unplanned new-device angioplasty from the New Approaches to Coronary Intervention (NACI) Registry. Am J Cardiol 1997; 80(10A): 40K–49K. 246 Priestley KA, Clague JR, Buller NP, et al. First clinical experience with a new flexible low profile metallic stent and delivery system. Eur Heart J 1996; 17: 438–444. 247 Haude M, Erbel R, Issa H, et al. Subacute thrombotic complications after intracoronary implantation of Palmaz-Schatz stents. Am Heart J 1993; 126: 15–22. 248 Carrozza JP Jr, Baim DS. Coronary stenting. In: DS Baim, W Grossman, eds. Cardiac Catheterization, Angiography, and Intervention. Baltimore : Williams and Wilkins, 1995, pp. 617–639. 249 Shaknovich A, Moses JW, Bailey S, et al. for the STRESS Investigators. Subacute stent thrombosis in the stent restenosis Study (STRESS). Clinical impact and predictive factors, (abstract) Circulation 1994; 90: I–650. 250 Nath FC, Muller DWM, Ellis SG, et al. Thrombosis of a flexible coil coronary stent: Frequency, predictors and clinical outcome. J Am Coll Cardiol 1993; 21: 622–627. 251 George BS, Voorhees WD III, Roubin GS, et al. Multicenter investigation of coronary stenting to treat acute or threatened closure after percutaneous transluminal coronary angioplasty: Clinical and angiographic outcomes. J Am Coll Cardiol 1993; 22: 135–143. 252 Popma JJ, Lansky AJ, Ito S, et al. Contemporary stent designs: Technical considerations, complications, role of intravascular ultrasound, and anticoagulation therapy. Prog Cardiovasc Dis 1996; 39: 111–128. 253 Baim DS, Carrozza JP Jr. Stent thrombosis. Closing in on the best preventive treatment. Circulation 1997; 95: 1098–1100. 254 Fischman DL, Leon M, Baim DS, et al. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994; 331: 496–501. 255 Serruys PW, de Jaegere P, Kiemneij F, et al. A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994; 331: 489–495. 256 Colombo A, Hall P, Nakamura S, et al. Intracoronary stenting without anticoagulation achieved with intravscular ultrasound guidance. Circulation 1995; 91: 1676–1688. 257 Gregorini L, Marco J, Fajadet J, et al. Ticlopidine and aspirin pretreatment reduces coagulation and platelet activation during coronary dilation procedures. J Am Coll Cardiol 1997; 29: 13–20. 258 Hass WK, Easton JD, Adam HP Jr. et al. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med 1989; 321: 501–507. 259 Bennett CL, Weinberg PD, Rozenberg-Ben-Dror K, et al. Thrombotic thrombocytopenic purpura associated with ticlopidine. Ann Intern Med 1998; 128: 541–544. 260 Schomig A, Meumann F-J, Kasuati A, et al. A randomized comparison of antiplatelet and anticoagulant therapy after placement of coronary-artery stents. N Engl J Med 1996; 334: 1084–1089. 261 Pan M, de Lezo JS, Velasco F, et al. Reduction of thrombotic and hemorrhagic complications after stent implantation. Am Heart J 1996; 132: 1119–1126. 262 Leon MD, Baim DS, Gordon P, et al. Clinical and angiographic results from the Stent Anticoagulation Regimen Study (STARS) (abstract). Circulation 1996; 94(Suppl. I): I–685. 263 Albiero R, Hall P, Itoh A, et al. Results of a consecutive series of patients receiving only antiplatelet therapy after optimized stent implantation. Comparison of aspirin alone versus combined ticlopidine and aspirin therapy. Circulation 1997; 95: 1145–1156. 264 Altmann DB, Racz M, Battleman DS, et al. Reduction in angioplasty complications after the introduction of coronary stents: Results from a consecutive series of 2,242 patients. Am Heart J 1996; 132: 503–507. 265 Rodriguez AE, Fernandez M, Santaera O, et al. Coronary stenting in patients undergoing percutaneous transluminal coronary angioplasty during acute myocardial infarction. Am J Cardiol 1996; 77: 685–689. 266 Schomig A, Kastrati A, Mudra H, et al. Four-year experience with Palmaz-Schatz stenting in coronary angioplasty complicated by dissection with threatened or present vessel closure. Circulation 1994; 90: 2716–2724. 267 Baim DS, Levine MJ, Leon MB, et al. for the U.S. Palmaz-Schatz Stent Investigators. Management of restenosis within the Palmaz-Schatz coronary stent (The U.S. Multicenter experience). Am J Cardiol 1993; 71: 364–366. 268 Topaz O, Vetrovec GW. The stenotic stent: Mechanisms and revascularization options. Cathet Cardiovasc Diagn 1996; 37: 293–299. 269 Colombo A, Ferraro M, Itoh A, et al. Results of coronary stenting for restenosis. J Am Coll Cardiol 1996; 28: 830–836. 270 Colombo A, Hall P, Nakamura S, et al. Angiographic follow-up and restenosis results after Palmaz-Schatz intracoronary stenting without anticoagulation. Circulation 1994; 90(Suppl. 1): I–124. 271 Holmes, DR Jr. Preventing coronary restenosis and complications. N Engl J Med 1997; 336: 1748–1749. 272 Rab ST, King SB III, Roubin GS, et al. Coronary aneuryms after stent placement. A suggestion of altered vessel wall healing in the presence of anti-inflammatory agents. J Am Coll Cardiol 1991; 18: 1524–1528. 273 Leroy O, Martin E, Prat A, et al. Fatal infection of coronary stent implantation. Cathet Cardiovasc Diagn 1996; 39: 168–170. Volume12, Issue5October 1999Pages 371-388 ReferencesRelatedInformation
Referência(s)